-
AbbVie Inc. (ABBV $222.44)
-
Danaher Corporation (DHR $219.75)
-
Eli Lilly and Company (LLY $1,025.00)
-
Thermo Fisher Scientific Inc (TMO $539.80)
-
Lantheus Holdings Inc. (LNTH $67.17)
Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?